1. Home
  2. DYN vs PRK Comparison

DYN vs PRK Comparison

Compare DYN & PRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • PRK
  • Stock Information
  • Founded
  • DYN 1984
  • PRK 1908
  • Country
  • DYN United States
  • PRK United States
  • Employees
  • DYN N/A
  • PRK N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • PRK Major Banks
  • Sector
  • DYN Health Care
  • PRK Finance
  • Exchange
  • DYN Nasdaq
  • PRK Nasdaq
  • Market Cap
  • DYN 2.6B
  • PRK 3.1B
  • IPO Year
  • DYN 2020
  • PRK N/A
  • Fundamental
  • Price
  • DYN $25.95
  • PRK $182.78
  • Analyst Decision
  • DYN Strong Buy
  • PRK Hold
  • Analyst Count
  • DYN 11
  • PRK 2
  • Target Price
  • DYN $51.18
  • PRK $130.00
  • AVG Volume (30 Days)
  • DYN 836.3K
  • PRK 56.5K
  • Earning Date
  • DYN 11-12-2024
  • PRK 01-21-2025
  • Dividend Yield
  • DYN N/A
  • PRK 1.69%
  • EPS Growth
  • DYN N/A
  • PRK 1.92
  • EPS
  • DYN N/A
  • PRK 8.46
  • Revenue
  • DYN N/A
  • PRK $484,274,000.00
  • Revenue This Year
  • DYN N/A
  • PRK N/A
  • Revenue Next Year
  • DYN N/A
  • PRK $1.47
  • P/E Ratio
  • DYN N/A
  • PRK $22.23
  • Revenue Growth
  • DYN N/A
  • PRK 2.58
  • 52 Week Low
  • DYN $11.66
  • PRK $123.08
  • 52 Week High
  • DYN $47.45
  • PRK $207.99
  • Technical
  • Relative Strength Index (RSI)
  • DYN 38.55
  • PRK 43.81
  • Support Level
  • DYN $25.27
  • PRK $182.52
  • Resistance Level
  • DYN $28.96
  • PRK $188.22
  • Average True Range (ATR)
  • DYN 1.41
  • PRK 3.86
  • MACD
  • DYN -0.23
  • PRK -1.39
  • Stochastic Oscillator
  • DYN 14.25
  • PRK 12.23

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.

About PRK Park National Corporation

Park National Corp is a diversified financial services company based in Newark, Ohio, consisting of 11 community banking divisions with more than 100 offices in Ohio and Kentucky. Park National provides banking and other financial services to consumers and businesses.

Share on Social Networks: